(Q38684877)

5 September 2017

title

Suggested new breakpoints of anti-MERS-CoV antibody ELISA titers: performance analysis of serologic tests (English)

1 reference

Middle East respiratory syndrome coronavirus

5 September 2017

main subject

0 references

15

C Drosten

1 reference

5 September 2017

J-H Ko

1

1 reference

5 September 2017

M A Müller

2

1 reference

5 September 2017

H Seok

3

1 reference

5 September 2017

G E Park

4

1 reference

5 September 2017

J Y Lee

5

1 reference

5 September 2017

S Y Cho

6

1 reference

5 September 2017

Y E Ha

7

1 reference

5 September 2017

J Y Baek

8

1 reference

5 September 2017

S H Kim

9

1 reference

5 September 2017

J-M Kang

10

1 reference

5 September 2017

Y-J Kim

11

1 reference

5 September 2017

I J Jo

12

1 reference

5 September 2017

C R Chung

13

1 reference

5 September 2017

M-J Hahn

14

1 reference

5 September 2017

C-I Kang

16

1 reference

5 September 2017

D R Chung

17

1 reference

5 September 2017

J-H Song

18

1 reference

5 September 2017

E-S Kang

19

1 reference

5 September 2017

K R Peck

20

1 reference

5 September 2017

publication date

11 July 2017

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

5 September 2017

published in

1 reference

https://scigraph.springernature.com/pub.10.1007/s10096-017-3043-3

5 September 2017

exact match

0 references

cites work

Middle East respiratory syndrome.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-017-3043-3

Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi Arabia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-017-3043-3

Serologic Evaluation of MERS Screening Strategy for Healthcare Personnel During a Hospital-Associated Outbreak.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-017-3043-3

Kinetics of Serologic Responses to MERS Coronavirus Infection in Humans, South Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-017-3043-3

Viral Shedding and Antibody Response in 37 Patients With Middle East Respiratory Syndrome Coronavirus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-017-3043-3

Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-017-3043-3

Control of an Outbreak of Middle East Respiratory Syndrome in a Tertiary Hospital in Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-017-3043-3

Predictive factors for pneumonia development and progression to respiratory failure in MERS-CoV infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-017-3043-3

Case definition and management of patients with MERS coronavirus in Saudi Arabia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-017-3043-3

Transmission of MERS-coronavirus in household contacts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-017-3043-3

Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-017-3043-3

Infectious Middle East Respiratory Syndrome Coronavirus Excretion and Serotype Variability Based on Live Virus Isolates from Patients in Saudi Arabia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-017-3043-3

Surveillance of the Middle East respiratory syndrome (MERS) coronavirus (CoV) infection in healthcare workers after contact with confirmed MERS patients: incidence and risk factors of MERS-CoV seropositivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-017-3043-3

Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28695355

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28695355

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S10096-017-3043-3

1 reference

Dimensions Publication ID

5 September 2017

1090613986

0 references

1 reference